Monday, January 26, 2026

Latest

Continued Pandemic Uncertainty Causes Bank of America to Defer $7.7 Billion in Commercial Loans

In response to a struggling economy amid the coronavirus pandemic, the Bank of America has decided to defer a total of $7.7 billion in loans for its commercial clients.

As of July 23, nearly 2% of the bank’s commercial clients have had their loans modified in some way, such as payment deferrals for durations up to 90 days or waivers on loan covenants. In the meantime, Bank of America’s consumer and small-business division had to defer a total of $28.5 billion in loans, with over of 1.4 million consumers requesting a delay on their credit card payments. Of those that were granted deferrals, approximately 61% have so far made some form of payment, while another 33% have been making timely payments each month.

The Bank of America anticipates the current economic uncertainty to continue for the time being, as coronavirus cases continue to mount and initial job claims fail to show signs of a significant improvement. As a result, the negative macroeconomic environment will most likely contribute to a deterioration of the bank’s businesses.

Information for this briefing was found via Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Japan Gold Intersects Gold Mineralization Drilling At Mizobe, Encounters Banded Chalcedony Vein

Antimony Resources Drills 5.10% Sb Over 4.0 Metres At Bald Hill

Related News

Could There Be a Global Food Shortage? You Betcha’

The COVID-19 pandemic has led to the UN warning the public about the possibility of...

Tuesday, March 31, 2020, 08:33:33 PM

Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments

Revive Therapeutics (CSE: RVV) this morning announced that on the heels of receiving FDA approval...

Wednesday, August 5, 2020, 09:50:58 AM

Gilead’s Antiviral Drug Fails to Treat Coronavirus, Preliminary Study Shows

Gilead Sciences Inc (NASDAQ: GILD) has been running a randomized clinical trial on the experimental...

Thursday, April 23, 2020, 04:16:38 PM

Provinces Reach Deal with Federal Government Over $19 Billion Safe Restart Agreement

Provincial and territorial governments have come a deal with the federal government, and as a...

Saturday, July 18, 2020, 03:55:00 PM

Datametrex Acquires Rights To Sell COVID-19 Home Test Kit

Datametrex AI (TSXV: DM) this morning had significant news in that it has secured the...

Tuesday, June 16, 2020, 08:15:19 AM